Mebeverine Hydrochloride Blue Bio Pharma (Uk) (Mebeverine Hydrochloride)

Mebeverine acts as a direct smooth‑muscle relaxant in the gut. By inhibiting calcium influx into smooth‑muscle cells, it reduces muscle contractility and spasm. This leads to decreased abdominal pain and a more regular pattern of bowel movements in patients with functional bowel disorders.

The appropriate dose of mebeverine is determined by the prescribing healthcare professional based on the individual’s condition, severity of symptoms and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety data for mebeverine in pregnancy and lactation are limited, and the product’s pregnancy category is unknown. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Mebeverine is a direct smooth‑muscle relaxant that does not possess significant anticholinergic activity, which can make it better tolerated than some anticholinergic antispasmodics that cause dry mouth or blurred vision. However, therapeutic choice depends on individual patient response, side‑effect profile and physician preference.

Mebeverine Hydrochloride tablets should be stored at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect from moisture and direct sunlight to maintain product stability.

Mebeverine is taken orally, usually with a glass of water. The exact timing (e.g., before meals or with food) and frequency are determined by the prescribing clinician based on the patient’s therapeutic needs.

Serious but rare risks include severe allergic reactions such as rash, urticaria or angioedema, significant hypotension, cardiac arrhythmias, and hepatic dysfunction. Patients should seek immediate medical attention if they experience any signs of an allergic reaction, fainting, rapid heartbeat or jaundice.

Mebeverine should be avoided in individuals with known hypersensitivity to mebeverine or any of its excipients. Caution is also advised for patients with severe hepatic or renal impairment, uncontrolled cardiac conditions, or those taking medications that may interact adversely, unless supervised by a healthcare professional.